000724790 000__ 03695cam\a2200457\i\4500
000724790 001__ 724790
000724790 005__ 20230306140551.0
000724790 006__ m\\\\\o\\d\\\\\\\\
000724790 007__ cr\cn\nnnunnun
000724790 008__ 141209t20152015nz\\\\\\ob\\\\000\0\eng\d
000724790 019__ $$a908082980
000724790 020__ $$a9783319121697$$qelectronic book
000724790 020__ $$a3319121693$$qelectronic book
000724790 020__ $$z9783319121680
000724790 0247_ $$a10.1007/978-3-319-12169-7$$2doi
000724790 035__ $$aSP(OCoLC)ocn897810391
000724790 035__ $$aSP(OCoLC)897810391$$z(OCoLC)908082980
000724790 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dGW5XE$$dYDXCP$$dOCLCF$$dDKU$$dCDX$$dIDEBK$$dE7B$$dNUI$$dEBLCP$$dVLB
000724790 049__ $$aISEA
000724790 050_4 $$aHD9665.4$$b.P43 2015eb
000724790 08204 $$a338.436151$$223
000724790 24500 $$aPharmaceutical prices in the 21st century$$h[electronic resource] /$$cZaheer-Ud-Din Babar, editor.
000724790 264_1 $$a[Auckland] :$$bAdis ;$$aCham ;$$aHeidelberg ;$$aNew York ;$$aDordrecht ;$$aLondon :$$bSpringer,$$c[2015]
000724790 264_4 $$c©2015
000724790 300__ $$a1 online resource.
000724790 336__ $$atext$$btxt$$2rdacontent
000724790 337__ $$acomputer$$bc$$2rdamedia
000724790 338__ $$aonline resource$$bcr$$2rdacarrier
000724790 504__ $$aIncludes bibliographical references.
000724790 5050_ $$aIntroduction -- Reference pricing strategies -- Differential pricing -- Prices of vaccines.
000724790 506__ $$aAccess limited to authorized users.
000724790 520__ $$aThe book is an essential, comprehensive text onglobal drug pricing and covers a range of pharmaceutical pricing issues. It has twenty-two chapters in total;nineteenof which are case studieson an array of high, middle, and low income countries. The final three chaptersdiscussvalue-based pricing, innovation, prices and the pharmaceutical industry and the link betweenpharmaceutical policy and pricing. As the pharmaceutical market continues to expand, a number of pharmaceutical pricing strategies have been employed to control drug expenditures. The book explores this phenomenon further and willserve a valuable resource for policy makers, funders, social insurance institutions and drug companies. ℗ℓAbout the author Zaheer-Ud-Din Babar, PhD is the Head of Pharmacy Practice at the School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and a PhD in pharmaceutical policy, Dr Babar is a recipient of the prestigious ℓ́ℓResearch Excellence Awardℓ́ℓ from the University of Auckland. His research program covers areas related to pharmaceutical policy and practice, encompassing access to and affordability of medicines, issues related to medicine pricing and pharmacoeconomics. Dr Babar has delivered invited lectures at Boston University School of Public Health, Harvard Medical School, the Austrian Health Institute and the Universities of Reading and Kingston. He has also acted as a consultant for the World Health Organization, Health Action International, the International Union against Tuberculosis and Lung Disease, the International Pharmaceutical Federation (FIP) and the Pharmaceutical Management Agency of New Zealand in the area of medicines pricing and policies. Dr Babar is the Editor in Chief of the Journal of Pharmaceutical Policy and Practice,℗ℓwww.joppp.org and can be reached at z.babar@auckland.ac.nz.
000724790 650_0 $$aDrugs$$xPrices.
000724790 650_0 $$aPharmaceutical policy.
000724790 650_0 $$aDrugs$$xMarketing.
000724790 7001_ $$aBabar, Zaheer-ud-din,$$eeditor.
000724790 77608 $$iPrint version:$$aBabar, Zaheer-Ud-Din.$$tPharmaceutical prices in the 21st century$$z9783319121680$$w(OCoLC)890614232
000724790 852__ $$bebk
000724790 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-12169-7$$zOnline Access$$91397441.1
000724790 909CO $$ooai:library.usi.edu:724790$$pGLOBAL_SET
000724790 980__ $$aEBOOK
000724790 980__ $$aBIB
000724790 982__ $$aEbook
000724790 983__ $$aOnline
000724790 994__ $$a92$$bISE